Evaxion is building a unique pipeline of immunotherapies and vaccines addressing two of the biggest health threats worldwide

Utilizing superior delivery technologies, we are rapidly expanding our preclinical pipeline and manifesting the ground-breaking potential of our immuno-oncology platform, PIONEER. The EDEN platform further enables us to investigate any bacterial infectious disease through innovative methods. Within a matter of weeks, new candidates can be generated and tested in animals, dramatically accelerating the speed of vaccine development, as well as reducing the cost and risk associated with discovery and preclinical development.

© Copyright 2020 EVAXION BIOTECH A/S - All rights reserved